Hostname: page-component-77c89778f8-gvh9x Total loading time: 0 Render date: 2024-07-20T20:26:57.879Z Has data issue: false hasContentIssue false
  • English
  • Français

Paraneoplastic Opsoclonus-Myoclonus Syndrome Associated with Non-Small Cell Lung Cancer

Published online by Cambridge University Press:  27 December 2023

David Bayless Open the ORCID record for David Bayless [Opens in a new window] ,
Christopher Itoh  and
Rafid Mustafa Open the ORCID record for Rafid Mustafa [Opens in a new window]
David Bayless
Affiliation:
Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA
Christopher Itoh
Affiliation:
Department of Neurology, Mayo Clinic, Rochester, MN, USA
Rafid Mustafa*
Affiliation:
Department of Neurology, Mayo Clinic, Rochester, MN, USA
*
Corresponding author: R. Mustafa; Email: mustafa.rafid@mayo.edu
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Keywords

Paraneoplastic conditionsocular motorneuro-ophthamology
Type
Letter to the Editor: New Observation
Information
Canadian Journal of Neurological Sciences , First View , pp. 1 - 3
Copyright
© The Author(s), 2023. Published by Cambridge University Press on behalf of Canadian Neurological Sciences Federation

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Wong, A. An update on opsoclonus. Curr Opin Neurol. 2007;20:25–31.CrossRefGoogle ScholarPubMed
Bataller, L. Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus. Brain. 2001;124:437–43.CrossRefGoogle ScholarPubMed
Armangué, T, Sabater, L, Torres-Vega, E, et al. Clinical and immunological features of opsoclonus-myoclonus syndrome in the era of neuronal cell surface antibodies. JAMA Neurol. 2016;73:417–24.CrossRefGoogle ScholarPubMed
Oh, SY, Kim, JS, Dieterich, M. Update on opsoclonus-myoclonus syndrome in adults. J Neurol. 2019;266:1541–8.CrossRefGoogle ScholarPubMed
Klaas, JP, Ahlskog, JE, Pittock, SJ, et al. Adult-onset opsoclonus-myoclonus syndrome. Arch Neurol. 2012;69:1598.CrossRefGoogle ScholarPubMed
Musunuru, K, Kesari, S. Paraneoplastic opsoclonus-myoclonus ataxia associated with non-small-cell lung carcinoma. J Neurooncol. 2008;90:213–6.CrossRefGoogle ScholarPubMed
Erlich, R, Morrison, C, Kim, B, Gilbert, MR, Alrajab, S. ANNA-2: an antibody associated with paraneoplastic opsoclonus in a patient with large-cell carcinoma of the lung with neuroendocrine features--correlation of clinical improvement with tumor response. Cancer Invest. 2004;22:257–61.CrossRefGoogle Scholar
Karasaki, T, Tanaka, M. Opsoclonus-myoclonus syndrome associated with non-small cell lung cancer. Asian Cardiovasc Thorac Ann. 2015;23:1113–5.CrossRefGoogle ScholarPubMed

Bayless et al. supplementary material

Bayless et al. supplementary material

Download Bayless et al. supplementary material(Video)
Video 11.5 MB